Ticker
URGNCompany Name
UROGEN PHARMA LTDSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Free Cash Flow | Free Cash Flow Margin | Revenues |
---|---|---|---|
6/30/2025 | $ -123.53M | -131.08% | $ 94.24M |
3/31/2025 | $ -107.39M | -116.9% | $ 91.87M |
12/31/2024 | $ -97.06M | -107.37% | $ 90.4M |
9/30/2024 | $ -96.38M | -107.85% | $ 89.36M |
6/30/2024 | $ -86.02M | -101.18% | $ 85.01M |
3/31/2024 | $ -82.47M | -97.83% | $ 84.3M |
12/31/2023 | $ -76.57M | -92.57% | $ 82.71M |
9/30/2023 | $ -85.28M | -110.36% | $ 77.28M |
6/30/2023 | $ -85.65M | -118.1% | $ 72.52M |
3/31/2023 | $ -89.62M | -131.83% | $ 67.98M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
FCF / Revenues
(=) FCF %
FCF % for UROGEN PHARMA LTD is calculated as follows: FCF [ $ -111.88M ] / Revenues [ $ 3.83M ]
(=) FCF % [ -2918.84% ]
Minimum
Sep 30, 2020
Maximum
Dec 31, 2023
Average
Median
filtered constituents | 3.18K |
---|---|
min | -58.23% |
max | 68.19% |
average | 7.86% |
median | 7.37% |
std | 19.48% |